Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CVS · against 1,216 other Healthcare companies
Ranked #616 of 1,217 · scores higher than 49% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 40–49, including CVS · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | CVS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 7.4% | 6.1% | 55% | 33% | |
| Earnings per share growthHigher is better · 682 reported | 7.0% | 9.7% | 47% | 33% | |
| 3-year revenue growthHigher is better · 1,192 reported | 7.0% | 5.8% | 54% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 616 | 406.2B KRW (≈$292M) | 49 | 51 | |
| 616 | 6.8B HKD (≈$867M) | 49 | 56 | |
| 616 | 78.6B JPY (≈$535M) | 49 | 74 | |
| 616 | 111.7B DKK (≈$16.8B) | 49 | 53 | |
| 616 | 116.9B USD | 49 | 47 | |
| 616 | 21.7B EUR (≈$23.9B) | 49 | 47 | |
| 616 | 17.9B ZAR (≈$986M) | 49 | 62 | |
| 616 | 6.6B USD | 49 | 61 | |
| 616 | 1.2B NOK (≈$115M) | 49 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score